Organon & Co. (OGN)
13.66
+0.01
(+0.07%)
USD |
NYSE |
Sep 15, 16:00
13.69
+0.03
(+0.22%)
Pre-Market: 08:44
Organon Total Liabilities (Quarterly) : 12.17B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.17B |
| March 31, 2026 | 12.09B |
| December 31, 2025 | 12.12B |
| September 30, 2025 | 12.65B |
| June 30, 2025 | 12.77B |
| March 31, 2025 | 12.61B |
| December 31, 2024 | 12.63B |
| September 30, 2024 | 12.26B |
| June 30, 2024 | 12.01B |
| March 31, 2024 | 11.84B |
| December 31, 2023 | 12.13B |
| September 30, 2023 | 11.60B |
| Date | Value |
|---|---|
| June 30, 2023 | 11.53B |
| March 31, 2023 | 11.50B |
| December 31, 2022 | 11.85B |
| September 30, 2022 | 11.50B |
| June 30, 2022 | 11.75B |
| March 31, 2022 | 11.85B |
| December 31, 2021 | 12.19B |
| September 30, 2021 | 12.95B |
| June 30, 2021 | 12.84B |
| March 31, 2021 | 4.92B |
| December 31, 2020 | 4.623B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 87.82B |
| Eli Lilly & Co. | 108.40B |
| Pfizer Inc. | 115.64B |
| Bristol Myers Squibb Co. | 65.32B |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 129.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.18B |
| Shareholders Equity (Quarterly) | 1.006B |
| Debt to Equity Ratio | 8.502 |
| Current Ratio | 1.954 |
| Net Debt Paydown Yield | 2.27% |